$COPY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anixa Biosciences Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Anixa Biosciences Inc. Get notifications about new insider transactions in Anixa Biosciences Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Buy | J | 1.84 | 1,634 | 3,007 | 9,383 | 7.7 K to 9.4 K (+21.09 %) |
Apr 23 2021 | COPY | Anixa Biosciences ... | Gottschalk Emily | Director | Buy | P | 4.49 | 10,000 | 44,900 | 25,600 | 15.6 K to 25.6 K (+64.10 %) |
Apr 20 2021 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Buy | P | 3.91 | 10,000 | 39,100 | 61,000 | 51 K to 61 K (+19.61 %) |
Mar 26 2021 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Buy | P | 4.84 | 45,000 | 217,800 | 865,326 | 820.3 K to 865.3 K (+5.49 %) |
Mar 26 2021 | COPY | Anixa Biosciences ... | Gottschalk Emily | Director | Buy | P | 4.88 | 15,600 | 76,128 | 15,600 | 0 to 15.6 K |
Feb 05 2021 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Gift | G | 0.00 | 200,000 | 0 | 820,326 | 1 M to 820.3 K (-19.60 %) |
Feb 05 2021 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Gift | G | 0.00 | 200,000 | 0 | 820,326 | 1 M to 820.3 K (-19.60 %) |
Feb 01 2021 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 3.73 | 10,000 | 37,300 | 272,000 | 262 K to 272 K (+3.82 %) |
Dec 28 2020 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Option Exercise | A | 2.83 | 100,000 | 283,000 | 100,000 | |
Dec 28 2020 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 2.83 | 1,000,000 | 2,830,000 | 1,000,000 | |
Nov 03 2020 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Buy | J | 1.56 | 1,918 | 2,992 | 7,749 | 5.8 K to 7.7 K (+32.89 %) |
Sep 14 2020 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Buy | P | 2.08 | 40,000 | 83,200 | 1,020,326 | 980.3 K to 1 M (+4.08 %) |
Sep 11 2020 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 2.11 | 28,000 | 59,080 | 262,000 | 234 K to 262 K (+11.97 %) |
Aug 17 2020 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | A | 2.68 | 30,000 | 80,400 | 30,000 | |
Aug 17 2020 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | A | 2.68 | 30,000 | 80,400 | 30,000 | |
Aug 17 2020 | COPY | Anixa Biosciences ... | MONAHAN JOHN J | Director | Option Exercise | A | 2.68 | 30,000 | 80,400 | 30,000 | |
Aug 17 2020 | COPY | Anixa Biosciences ... | Gottschalk Emily | Director | Option Exercise | A | 2.68 | 30,000 | 80,400 | 30,000 | |
Aug 17 2020 | COPY | Anixa Biosciences ... | Cavalier David | Director | Option Exercise | A | 2.68 | 30,000 | 80,400 | 30,000 | |
Aug 17 2020 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Option Exercise | A | 2.68 | 30,000 | 80,400 | 30,000 | |
Jun 17 2020 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Buy | P | 2.27 | 24,500 | 55,615 | 980,326 | 955.8 K to 980.3 K (+2.56 %) |
Jun 16 2020 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Buy | P | 2.27 | 31,083 | 70,558 | 955,826 | 924.7 K to 955.8 K (+3.36 %) |
Jun 16 2020 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Buy | P | 2.27 | 31,083 | 70,558 | 955,826 | 924.7 K to 955.8 K (+3.36 %) |
Jun 12 2020 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 2.03 | 20,000 | 40,600 | 234,000 | 214 K to 234 K (+9.35 %) |
May 04 2020 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Buy | J | 1.61 | 1,867 | 3,006 | 5,829 | 4 K to 5.8 K (+47.12 %) |
Mar 17 2020 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Buy | P | 2.12 | 5,799 | 12,294 | 924,743 | 918.9 K to 924.7 K (+0.63 %) |
Mar 12 2020 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Buy | P | 1.84 | 10,000 | 18,400 | 41,000 | 31 K to 41 K (+32.26 %) |
Mar 12 2020 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 1.82 | 20,000 | 36,400 | 214,000 | 194 K to 214 K (+10.31 %) |
Mar 10 2020 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Buy | P | 2.71 | 10,000 | 27,100 | 31,000 | 21 K to 31 K (+47.62 %) |
Jan 21 2020 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Buy | P | 3.53 | 10,000 | 35,300 | 21,000 | 11 K to 21 K (+90.91 %) |
Jan 16 2020 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Buy | P | 3.32 | 5,000 | 16,600 | 918,944 | 913.9 K to 918.9 K (+0.55 %) |
Jan 15 2020 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Buy | P | 3.22 | 7,400 | 23,828 | 913,944 | 906.5 K to 913.9 K (+0.82 %) |
Jan 14 2020 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 2.99 | 20,000 | 59,800 | 194,000 | 174 K to 194 K (+11.49 %) |
Dec 16 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 3.84 | 520,000 | 1,996,800 | 520,000 | |
Dec 16 2019 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Option Exercise | A | 3.84 | 100,000 | 384,000 | 100,000 | |
Nov 04 2019 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Buy | J | 3.29 | 912 | 3,000 | 3,962 | 3.1 K to 4 K (+29.90 %) |
Nov 04 2019 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Buy | J | 3.29 | 912 | 3,000 | 3,962 | 3.1 K to 4 K (+29.90 %) |
Oct 24 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | A | 3.87 | 45,000 | 174,150 | 45,000 | |
Oct 24 2019 | COPY | Anixa Biosciences ... | MONAHAN JOHN J | Director | Option Exercise | A | 3.87 | 45,000 | 174,150 | 45,000 | |
Oct 24 2019 | COPY | Anixa Biosciences ... | Gottschalk Emily | Director | Option Exercise | A | 3.87 | 45,000 | 174,150 | 45,000 | |
Oct 24 2019 | COPY | Anixa Biosciences ... | Cavalier David | Director | Option Exercise | A | 3.87 | 45,000 | 174,150 | 45,000 | |
Oct 24 2019 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Option Exercise | A | 3.87 | 45,000 | 174,150 | 45,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | A | 2.92 | 16,000 | 46,720 | 16,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | D | 0.67 | 16,000 | 10,720 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | A | 2.58 | 16,000 | 41,200 | 16,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | D | 0.67 | 16,000 | 10,720 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | A | 2.58 | 16,000 | 41,200 | 16,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | D | 0.67 | 16,000 | 10,720 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | A | 2.58 | 120,000 | 309,000 | 120,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | D | 0.67 | 120,000 | 80,400 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | A | 0.82 | 6,000 | 4,920 | 6,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | D | 0.67 | 6,000 | 4,020 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | A | 2.58 | 16,000 | 41,200 | 16,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | D | 0.67 | 16,000 | 10,720 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | A | 2.58 | 40,000 | 103,000 | 40,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | D | 0.67 | 40,000 | 26,800 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | A | 2.58 | 30,000 | 77,250 | 30,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Option Exercise | D | 0.67 | 30,000 | 20,100 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | MONAHAN JOHN J | Director | Option Exercise | A | 5.30 | 12,000 | 63,600 | 12,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | MONAHAN JOHN J | Director | Option Exercise | D | 0.67 | 12,000 | 8,040 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | MONAHAN JOHN J | Director | Option Exercise | A | 3.13 | 6,000 | 18,780 | 6,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | MONAHAN JOHN J | Director | Option Exercise | D | 0.67 | 6,000 | 4,020 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 2.92 | 200,000 | 584,000 | 200,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | D | 0.67 | 200,000 | 134,000 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 2.58 | 40,000 | 103,000 | 40,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | D | 0.67 | 40,000 | 26,800 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 2.58 | 213,333 | 549,332 | 213,333 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | D | 0.67 | 213,333 | 142,933 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 2.58 | 106,667 | 274,668 | 106,667 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | D | 0.67 | 106,667 | 71,467 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 2.58 | 320,000 | 824,000 | 320,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | D | 0.67 | 320,000 | 214,400 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Option Exercise | A | 0.96 | 200,000 | 192,000 | 200,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Option Exercise | D | 0.67 | 200,000 | 134,000 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Option Exercise | A | 4.85 | 50,000 | 242,500 | 50,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Option Exercise | D | 0.67 | 50,000 | 33,500 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Option Exercise | A | 5.30 | 12,000 | 63,600 | 12,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Option Exercise | D | 0.67 | 12,000 | 8,040 | 0 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Option Exercise | A | 3.13 | 6,000 | 18,780 | 6,000 | |
Sep 20 2019 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Option Exercise | D | 0.67 | 6,000 | 4,020 | 0 | |
Sep 16 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Buy | P | 4.10 | 15,000 | 61,500 | 906,544 | 891.5 K to 906.5 K (+1.68 %) |
Sep 16 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 4.12 | 10,000 | 41,200 | 174,000 | 164 K to 174 K (+6.10 %) |
May 02 2019 | COPY | Anixa Biosciences ... | Catelani Michael | COO & CFO | Buy | J | 3.43 | 800 | 2,744 | 3,050 | 2.3 K to 3.1 K (+35.56 %) |
Apr 29 2019 | COPY | Anixa Biosciences ... | MONAHAN JOHN J | Director | Buy | P | 4.22 | 900 | 3,798 | 50,900 | 50 K to 50.9 K (+1.80 %) |
Apr 29 2019 | COPY | Anixa Biosciences ... | Cavalier David | Director | Buy | P | 4.21 | 2,000 | 8,420 | 2,000 | 0 to 2 K |
Apr 29 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 4.21 | 4,000 | 16,840 | 164,000 | 160 K to 164 K (+2.50 %) |
Apr 26 2019 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Buy | P | 4.28 | 10,000 | 42,800 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
Apr 24 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 4.27 | 10,000 | 42,700 | 160,000 | 150 K to 160 K (+6.67 %) |
Apr 22 2019 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Buy | P | 4.09 | 50,000 | 204,500 | 891,544 | 841.5 K to 891.5 K (+5.94 %) |
Oct 26 2018 | COPY | Anixa Biosciences ... | Titterton Lewis H jr | Director | Buy | P | 4.05 | 2,000 | 8,100 | 841,544 | 839.5 K to 841.5 K (+0.24 %) |
Oct 25 2018 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 3.90 | 11,000 | 42,900 | 150,000 | 139 K to 150 K (+7.91 %) |
Oct 09 2018 | COPY | Anixa Biosciences ... | MONAHAN JOHN J | Director | Option Exercise | A | 5.29 | 45,000 | 238,050 | 45,000 | |
Oct 09 2018 | COPY | Anixa Biosciences ... | MONAHAN JOHN J | Director | Option Exercise | A | 5.29 | 45,000 | 238,050 | 45,000 | |
Oct 09 2018 | COPY | Anixa Biosciences ... | Cavalier David | Director | Option Exercise | A | 5.29 | 45,000 | 238,050 | 45,000 | |
Oct 09 2018 | COPY | Anixa Biosciences ... | Cavalier David | Director | Option Exercise | A | 5.29 | 45,000 | 238,050 | 45,000 | |
Oct 09 2018 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Option Exercise | A | 5.29 | 45,000 | 238,050 | 45,000 | |
Oct 09 2018 | COPY | Anixa Biosciences ... | Baskies Arnold M | Director | Option Exercise | A | 5.29 | 45,000 | 238,050 | 45,000 | |
Sep 19 2018 | COPY | ITUS Corp | Catelani Michael | COO & CFO | Buy | P | 4.45 | 2,250 | 10,013 | 2,250 | 0 to 2.3 K |
Sep 19 2018 | COPY | ITUS Corp | Catelani Michael | COO & CFO | Buy | P | 4.45 | 2,250 | 10,013 | 2,250 | 0 to 2.3 K |
Sep 18 2018 | COPY | ITUS Corp | KUMAR AMIT | Chief Executive Off ... | Buy | P | 4.08 | 3,000 | 12,240 | 139,000 | 136 K to 139 K (+2.21 %) |
Sep 17 2018 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Buy | P | 3.98 | 5,000 | 19,900 | 839,544 | 834.5 K to 839.5 K (+0.60 %) |
Sep 14 2018 | COPY | ITUS Corp | KUMAR AMIT | Chief Executive Off ... | Buy | P | 3.84 | 3,000 | 11,520 | 136,000 | 133 K to 136 K (+2.26 %) |
Sep 13 2018 | COPY | ITUS Corp | KUMAR AMIT | Chief Executive Off ... | Buy | P | 3.96 | 4,112 | 16,284 | 133,000 | 128.9 K to 133 K (+3.19 %) |
Sep 12 2018 | COPY | ITUS Corp | KUMAR AMIT | Chief Executive Off ... | Buy | P | 3.99 | 4,480 | 17,875 | 128,888 | 124.4 K to 128.9 K (+3.60 %) |
Jul 27 2018 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 3.46 | 300,000 | 1,038,000 | 300,000 | |
Jul 27 2018 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 3.46 | 300,000 | 1,038,000 | 300,000 | |
May 14 2018 | COPY | ITUS Corp | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 3.70 | 1,500,000 | 5,550,000 | 1,500,000 | |
May 14 2018 | COPY | ITUS Corp | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 3.70 | 600,000 | 2,220,000 | 600,000 | |
May 14 2018 | COPY | ITUS Corp | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 0.00 | 1,500,000 | 0 | 1,500,000 | |
May 14 2018 | COPY | ITUS Corp | Catelani Michael | Chief Operating Off ... | Option Exercise | A | 3.70 | 500,000 | 1,850,000 | 500,000 | |
Apr 11 2018 | COPY | ITUS Corp | WILLIAMS RICHARD H | Director | Sell | S | 4.64 | 25,000 | 116,000 | 25,000 | 50 K to 25 K (-50.00 %) |
Oct 23 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | M | 0.67 | 2,400 | 1,608 | 0 | |
Oct 23 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Buy | M | 0.67 | 2,400 | 1,608 | 834,544 | 832.1 K to 834.5 K (+0.29 %) |
Oct 02 2017 | COPY | ITUS Corp | WILLIAMS RICHARD H | Director | Option Exercise | A | 2.27 | 50,000 | 113,500 | 50,000 | |
Oct 02 2017 | COPY | ITUS Corp | WILLIAMS RICHARD H | Director | Option Exercise | A | 2.27 | 50,000 | 113,500 | 50,000 | |
Oct 02 2017 | COPY | ITUS Corp | WILLIAMS RICHARD H | Director | Grant | A | 0.00 | 50,000 | 0 | 100,000 | 50 K to 100 K (+100.00 %) |
Sep 26 2017 | COPY | ITUS Corp | MONAHAN JOHN J | Director | Option Exercise | A | 2.27 | 50,000 | 113,500 | 50,000 | |
Sep 26 2017 | COPY | ITUS Corp | MONAHAN JOHN J | Director | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Sep 26 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 2.27 | 50,000 | 113,500 | 50,000 | |
Sep 26 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Grant | A | 0.00 | 50,000 | 0 | 832,144 | 782.1 K to 832.1 K (+6.39 %) |
Sep 26 2017 | COPY | ITUS Corp | JOHNSON BRUCE F | Director | Option Exercise | A | 2.27 | 50,000 | 113,500 | 50,000 | |
Sep 26 2017 | COPY | ITUS Corp | JOHNSON BRUCE F | Director | Grant | A | 0.00 | 50,000 | 0 | 604,817 | 554.8 K to 604.8 K (+9.01 %) |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 0.67 | 16,000 | 10,720 | 16,000 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | D | 2.92 | 16,000 | 46,720 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 0.67 | 16,000 | 10,720 | 16,000 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | D | 2.58 | 16,000 | 41,200 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 0.67 | 16,000 | 10,720 | 16,000 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | D | 2.58 | 16,000 | 41,200 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 0.67 | 120,000 | 80,400 | 120,000 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | D | 2.58 | 120,000 | 309,000 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 0.67 | 2,400 | 1,608 | 2,400 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | D | 2.58 | 2,400 | 6,180 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 0.67 | 6,000 | 4,020 | 6,000 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | D | 0.82 | 6,000 | 4,920 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 0.67 | 16,000 | 10,720 | 16,000 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | D | 2.58 | 16,000 | 41,200 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 0.67 | 40,000 | 26,800 | 40,000 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | D | 2.58 | 40,000 | 103,000 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | A | 0.67 | 30,000 | 20,100 | 30,000 | |
Sep 08 2017 | COPY | ITUS Corp | Titterton Lewis H jr | Director | Option Exercise | D | 2.58 | 30,000 | 77,250 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Baskies Arnold M | Director | Option Exercise | A | 0.67 | 12,000 | 8,040 | 12,000 | |
Sep 08 2017 | COPY | ITUS Corp | Baskies Arnold M | Director | Option Exercise | D | 5.30 | 12,000 | 63,600 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Baskies Arnold M | Director | Option Exercise | A | 0.67 | 6,000 | 4,020 | 6,000 | |
Sep 08 2017 | COPY | ITUS Corp | Baskies Arnold M | Director | Option Exercise | D | 3.13 | 6,000 | 18,780 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Baskies Arnold M | Director | Option Exercise | A | 0.67 | 20,000 | 13,400 | 20,000 | |
Sep 08 2017 | COPY | ITUS Corp | Fox Dale | Director | Option Exercise | A | 0.67 | 12,000 | 8,040 | 12,000 | |
Sep 08 2017 | COPY | ITUS Corp | Fox Dale | Director | Option Exercise | D | 5.30 | 12,000 | 63,600 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Fox Dale | Director | Option Exercise | A | 0.67 | 12,000 | 8,040 | 12,000 | |
Sep 08 2017 | COPY | ITUS Corp | Fox Dale | Director | Option Exercise | D | 2.92 | 12,000 | 35,040 | 0 | |
Sep 08 2017 | COPY | ITUS Corp | Fox Dale | Director | Option Exercise | A | 0.67 | 12,000 | 8,040 | 12,000 | |
Sep 08 2017 | COPY | ITUS Corp | Fox Dale | Director | Option Exercise | D | 2.58 | 12,000 | 30,900 | 0 |